News
AHN Cancer Institute To Offer Groundbreaking Treatment For Metastatic Melanoma; The One-Time Treatment, Made By Iovance Biotherapeutics, Is The First FDA-Approved T-Cell Therapy For Solid Tumors
22 Apr 24
News
10 Health Care Stocks With Whale Alerts In Today's Session
19 Mar 24
Options
Piper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Know
14 Mar 24
Analyst Ratings
Piper Sandler Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $19
14 Mar 24
News, Price Target, Analyst Ratings
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
13 Mar 24
Options, Markets
Truist Securities Maintains Buy Rating for Iovance Biotherapeutics: Here's What You Need To Know
7 Mar 24
Analyst Ratings
Truist Securities Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $26
7 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target
4 Mar 24
News, Price Target, Reiteration, Analyst Ratings
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
1 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Wells Fargo Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $25
1 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
29 Feb 24
Options
Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity
29 Feb 24
Options, Markets
Goldman Sachs Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $21
29 Feb 24
News, Price Target, Analyst Ratings
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $22
29 Feb 24
News, Price Target, Analyst Ratings
Earnings Scheduled For February 28, 2024
28 Feb 24
Earnings
Iovance Biotherapeutics's Earnings: A Preview
27 Feb 24
Earnings
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
23 Feb 24
Options, Markets
Iovance Biotherapeutics Unusual Options Activity For February 22
22 Feb 24
Options, Markets
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
21 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Press releases
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
24 Apr 24
News, Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19 Apr 24
Markets, Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
22 Mar 24
News, Financing, Press Releases
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
4 Mar 24
Health Care, Press Releases
Iovance Biotherapeutics to Present at Upcoming Conferences
1 Mar 24
News, Health Care, Press Releases
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
28 Feb 24
Earnings, Press Releases
Thinking about buying stock in Synchronoss, ZIM Integrated Shipping, Iovance Biotherapeutics, Sirius XM, or Lincoln Educational Services?
22 Feb 24
Opinion, Press Releases
Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
22 Feb 24
Press Releases
Thinking about buying stock in C4 Therapeutics, Safety Shot, Intuitive Machines, Cardiol Therapeutics, or Iovance Biotherapeutics?
21 Feb 24
Small Cap, Opinion, Press Releases
Thinking about buying stock in Iovance Biotherapeutics, Alaska Energy Metals, Foremost Lithium Resource & Technology, Shineco, or Intuitive Machines?
20 Feb 24
Opinion, Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16 Feb 24
Press Releases
Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
16 Feb 24
News, Health Care, Press Releases
Iovance's AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
16 Feb 24
Press Releases, General
Cutaneous Melanoma Market Size in 7MM is Anticipated to See a Significant Change by 2032
12 Feb 24
News, Press Releases